A03075 Summary:

BILL NO    A03075A

SAME AS    Same as S 1197-A

SPONSOR    Cusick (MS)

COSPNSR    Pheffer, Ortiz, Abbate, Schimminger, Lopez V, Weisenberg, Boyland,
           Schroeder, Millman, Sweeney, Clark, Titone

MLTSPNSR   Aubry, Colton, Destito, Gabryszak, Gunther, Hooper, Lupardo, McEneny,
           Peoples-Stokes, Rivera J

Add Art 27-CCC S2747, Pub Health L; add SS209-H & 630-c, Tax L; add S97-jjjj,
St Fin L

Provides a program to promote leukemia, lymphoma and myeloma research education
and treatment and establishes the leukemia, lymphoma and myeloma research
education and treatment fund; authorizes the commissioner of taxation and
finance to create a check-off gift an individual income tax returns for
contributions to leukemia, lymphoma and myeloma research, education and
treatment.

A03075 Actions:

BILL NO    A03075A

01/22/2009 referred to health
02/04/2009 reported referred to ways and means
06/08/2009 reported referred to rules
06/10/2009 reported 
06/10/2009 rules report cal.117
06/10/2009 ordered to third reading rules cal.117
06/10/2009 passed assembly
06/10/2009 delivered to senate
06/11/2009 REFERRED TO RULES
01/06/2010 DIED IN SENATE
01/06/2010 RETURNED TO ASSEMBLY
01/06/2010 ordered to third reading cal.252
01/25/2010 amended on third reading 3075a

A03075 Votes:

BILL: A03075  DATE: 06/10/2009  MOTION:                       YEA/NAY: 140/002

Abbate  Y  Cahill  Y  Englebr Y  Hooper  Y  Maisel  Y  Powell  Y  Skartad Y
Alessi  Y  Calhoun NO Errigo  Y  Hoyt    Y  Markey  Y  Pretlow Y  Spano   Y
Alfano  Y  Camara  Y  Espaill Y  Hyer-Sp Y  Mayerso Y  Quinn   Y  Stirpe  Y
Amedore ER Canestr Y  Farrell Y  Jacobs  Y  McDonou Y  Rabbitt Y  Sweeney Y
Arroyo  ER Carrozz ER Fields  Y  Jaffee  Y  McEneny Y  Raia    Y  Tedisco Y
Aubry   Y  Castro  Y  Finch   Y  Jeffrie Y  McKevit ER Ramos   Y  Thiele  Y
Bacalle Y  Christe Y  Fitzpat Y  John    Y  Meng    ER Reilich Y  Titone  Y
Ball    Y  Clark   Y  Gabrysz Y  Jordan  Y  Miller  Y  Reilly  Y  Titus   Y
Barclay Y  Colton  Y  Galef   Y  Kavanag Y  Millman Y  Rive J  Y  Tobacco Y
Barra   Y  Conte   Y  Gantt   Y  Kellner Y  Molinar Y  Rive N  Y  Towns   Y
Barron  Y  Cook    Y  Gianari Y  Kolb    Y  Morelle Y  Rive PM Y  Townsen Y
Benedet Y  Corwin  Y  Gibson  Y  Koon    Y  Nolan   Y  Robinso Y  Walker  Y
Benjami Y  Crespo  Y  Giglio  Y  Lancman Y  Oaks    Y  Rosenth Y  Weinste Y
Bing    Y  Crouch  Y  Glick   Y  Latimer Y  O'Donne Y  Russell ER Weisenb Y
Boyland Y  Cusick  Y  Gordon  Y  Lavine  Y  O'Mara  Y  Saladin ER Weprin  Y
Boyle   Y  Cymbrow Y  Gottfri NO Lentol  Y  Ortiz   ER Sayward Y  Wright  Y
Bradley Y  DelMont Y  Gunther Y  Lifton  Y  Parment Y  Scarbor Y  Zebrows Y
Brennan Y  DenDekk Y  Hawley  Y  Lope PD Y  Paulin  Y  Schimel Y  Mr Spkr Y
Brodsky Y  Destito Y  Hayes   Y  Lope VJ Y  Peoples Y  Schimmi Y
Brook-K Y  Dinowit Y  Heastie Y  Lupardo Y  Peralta Y  Schroed Y
Burling Y  Duprey  Y  Hevesi  Y  Magee   Y  Perry   Y  Scozzaf Y
Butler  Y  Eddingt Y  Hikind  Y  Magnare Y  Pheffer Y  Seminer Y

A03075 Memo:

BILL NUMBER:A3075A

TITLE  OF BILL:   An act to amend the public health law, the tax law and
the state finance law, in relation to providing for taxpayer  gifts  for
leukemia,  lymphoma  and  myeloma  research, education and treatment and
establishing the leukemia research, education and treatment fund

PURPOSE OR GENERAL IDEA OF BILL: The purpose of this bill is to  provide
easy  access  to  help  fund and support Leukemia, Lymphoma, and Myeloma
research, education and treatment.

SUMMARY OF SPECIFIC PROVISIONS: Section 1 - Amends the public health law
by adding a new article 27-CCC. The new article provides the Commission-
er of Health with the powers to: develop programs  concerning  Leukemia,
Lymphoma,  and  Myeloma,  to  accept and expend grants, awards and other
funding, and to enter into contracts necessary for  program  development
and  granting. Section 2 - Amends the law by adding a new section 209-H.
The new section provides for the Commissioner of Taxation and Finance to
include a space on the corporate income tax return for contributions  to
Leukemia,  Lymphoma,  and  Myeloma  research,  education  and treatment.
Section 3 - Amends part 2 of article 22 of the tax  law  by  adding  new
section 630-c. The new section provides for the Commissioner of Taxation
and  Finance  to include a space on the individual income tax return for
contributions to Leukemia, Lymphoma, and Myeloma research, education and
treatment.   Section 4 Amends the state finance  law  by  adding  a  new
section  97-a.    The  new  section  provides for the establishment of a
special fund, consisting of revenues received under  section  209-H  and
630-c  of  the  tax  law  and any other moneys appropriated, credited or
transferred, for Leukemia, Lymphoma and Myeloma research, education  and
treatment.  The custody of this fund will be held jointly by the Commis-
sioner of Taxation and Finance and the  Comptroller.  Further,  the  new
section  provides that all monies in the fund to be used only for Leuke-
mia, Lymphoma and Myeloma research,  education  and  treatment  programs
approved  by  the  Department  of  Health. Additionally, the new section
provides that the Comptroller must approve releases of  money  that  are
certified  by  the Commissioner of Health and that all money in the fund
should be used prior to the end of the fiscal year.

JUSTIFICATION: Research and treatment efforts for many diseases, includ-
ing Alzheimer's and breast cancer, have benefited from additional  fund-
ing resulting from having a "check-off box" placed on the individual and
corporate  income  tax returns. Leukemia, Lymphoma and Myeloma are blood
cancers originating in the bone marrow and  correlate  with  each  other
because  of  the unrestrained growth of the cells and the parallel func-
tions which they possess. Leukemia, although more common in adults  over
the  age  of 64, is still the leading cause of disease death of children
under 15 yrs old, with Acute Lymphocytic Leukemia (ALL) being  the  most
common  form  of  Leukemia  in children. Treatment advances for Leukemia
have proven to be prevalent in the survival rate over  the  years,  with
the  survival  rate  increasing from 4% in 1960 to 85% in 1999. Lymphoma
involves two particular forms including Non-Hodgkin, which is the  fifth
most  common  cancer  in  the  U.S.  and  Hodgkin Lymphoma, which mostly

affects adolescents and young adults. Myeloma occurs  mostly  in  people
over  60  yrs  old with males having a 50% higher chance than females of
being diagnosed. Each year an estimated 106,200  people  in  the  United
States  are diagnosed with Leukemia, Lymphoma. or Myeloma.  At the pres-
ent time, an estimated 670,950 Americans have  blood  cancers.  Approxi-
mately  57,500  Americans will die from these hematological malignancies
this year. In New York State alone, there are approximately 6,600 people
diagnosed with a blood cancer each year and 3,500 people will succumb to
this disease.

PRIOR LEGISLATIVE HISTORY:2009: A.3075 Passed Assembly;  2008:  A.1558-C
Passed  Assembly;  2007: A.1558-A Passed Assembly; 2006: A.3338-A Passed
Assembly; S.2871-A- Died in Senate Health; 2005: A3338-Passed  Assembly;
2004:  A.9816-Passed Assembly; S.6491-Died in Senate Health

FISCAL IMPLICATIONS: Minimal to the state.

EFFECTIVE  DATE:  This act shall apply to taxable years commencing on or
after January 1, 2011.